Record 1017 View: Standard | Glossary HistCite Guide |
Author(s): Angers S; Salahpour A; Bouvier M
Title: Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function
Source: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 42: 409-435
Date: 2002
Document Type: Journal : Review
DOI:
Language: English
Comment:
Address: Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.
Univ Montreal, Grp Rech Syst Nerveux Autonome, Montreal, PQ H3C 3J7, Canada. Reprint: Angers, S, Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.
E-mail:
Author Keywords: dimerization; energy transfer; signal transduction; trafficking
KeyWords Plus: METABOTROPIC GLUTAMATE-RECEPTOR; ENERGY-TRANSFER BRET; HIV-1 INFECTION;
GABA(B) RECEPTOR; ERYTHROPOIETIN RECEPTOR; HETEROMERIC COMPLEXES;
HORMONE RECEPTORS; LINKED RECEPTORS; ACTIVATION; DOPAMINE
Abstract: In the last four to five years, the view that G protein-coupled receptors (GPCRs) function as monomeric proteins has, been challenged by numerous studies, which suggests that GPCRs exist as dimers or even higher-structure oligomers. Recently, biophysical methods based on luminescence and fluorescence energy transfer have confirmed the existence of such oligomeric complexes in living cells. Although no consensus exists on the role of receptor dimerization, converging evidence suggests potential roles in various aspects of receptor biogenesis and function. In several cases, receptors appear to fold as constitutive dimers early after biosynthesis, whereas ligand-promoted dimerization at the cell surface has been proposed for others. The reports of heterodimerization between receptor subtypes suggest at potential level of receptor complexity that could account for previously unexpected pharmacological diversities. In addition to fundamentally changing our views on the structure and activation processes of GPCRs, the concept of homo-and heterodimerization could have dramatic impacts on drug development and screening.
Cited References: ABDALLA S, 2000, NATURE, V407, P94 ALDECOA A, 2000, FEBS LETT, V471, P156 ANGERS S, 2000, P NATL ACAD SCI USA, V97, P3684 BAI M, 1998, J BIOL CHEM, V273, P23605 BAI M, 1999, P NATL ACAD SCI USA, V96, P2834 BENKIRANE M, 1997, J BIOL CHEM, V272, P30603 CALVER AR, 2001, J NEUROSCI, V21, P1203 CARRITHERS MD, 1996, CHEM BIOL, V3, P537 CIRUELA F, 1995, J NEUROSCI RES, V42, P818 CONN PM, 1982, NATURE, V296, P653 CORNEA A, 2001, J BIOL CHEM, V276, P2153 CVEJIC S, 1997, J BIOL CHEM, V272, P26959 GALVEZ T, 2000, J BIOL CHEM, V275, P41166 GALVEZ T, 2001, EMBO J, V20, P2152 GEORGE SR, 1998, J BIOL CHEM, V273, P30244 GEORGE SR, 2000, J BIOL CHEM, V275, P26128 GINES S, 2000, P NATL ACAD SCI USA, V97, P8606 GOMES I, 2000, J NEUROSCI, V20, ARRC110 GREGORY H, 1982, NATURE, V300, P269 HEBERT TE, 1996, J BIOL CHEM, V271, P16384 HEIM R, 1996, CURR BIOL, V6, P178 HILAIRET S, 2001, J BIOL CHEM, V276, P29575 HONDA A, 2001, P NATL ACAD SCI USA, V98, P2437 HORVAT RD, 2001, MOL ENDOCRINOL, V15, P695 HOVIUS R, 2000, TRENDS PHARMACOL SCI, V21, P266 JONES KA, 1998, NATURE, V396, P674 JORDAN BA, 1999, NATURE, V399, P697 JORDAN BA, 2001, P NATL ACAD SCI USA, V98, P343 KARPA KD, 2000, MOL PHARMACOL, V58, P677 KAUPMANN K, 1998, NATURE, V396, P683 KROEGER KM, 2001, J BIOL CHEM, V276, P12736 KUNER R, 1999, SCIENCE, V283, P74 KUNISHIMA N, 2000, NATURE, V407, P971 LEUTHAUSER K, 2000, BIOCHEM J 2, V351, P347 LIU R, 1996, CELL, V86, P367 LIVNAH O, 1999, SCIENCE, V283, P987 LLOPIS J, 2000, P NATL ACAD SCI USA, V97, P4363 MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103 MAGGIO R, 1999, J PHARMACOL EXP THER, V291, P251 MARGETAMITROVIC M, 2000, NEURON, V27, P97 MCLATCHIE LM, 1998, NATURE, V393, P333 MCVEY M, 2001, J BIOL CHEM, V276, P14092 MELLADO M, 1999, NATURE, V400, P723 MELLADO M, 2001, EMBO J, V20, P2497 MIJARES A, 2000, MOL PHARMACOL, V58, P373 MIYAWAKI A, 1997, NATURE, V388, P882 MONNOT C, 1996, J BIOL CHEM, V271, P1507 MORELLO JP, 2001, BIOCHEMISTRY-US, V40, P6766 NAKANISHIMATSUI M, 2000, NATURE, V404, P609 NELSON G, 2001, CELL, V106, P381 NG GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200 NG GYK, 1999, J BIOL CHEM, V274, P7607 NG GYK, 2001, MOL PHARMACOL, V59, P144 OVERTON MC, 2000, CURR BIOL, V10, P341 PAGANO A, 2001, J NEUROSCI, V21, P1189 PFEIFFER M, 2001, J BIOL CHEM, V276, P14027 REDDY PS, 1998, BIOESSAYS, V20, P546 REMY I, 1999, SCIENCE, V283, P990 ROCHEVILLE M, 2000, J BIOL CHEM, V275, P7862 ROCHEVILLE M, 2000, SCIENCE, V288, P154 RODRIGUEZFRADE JM, 1999, P NATL ACAD SCI USA, V96, P3628 ROESS DA, 2000, ENDOCRINOLOGY, V141, P4518 ROMANO C, 1996, J BIOL CHEM, V271, P28612 SALAHPOUR A, 2000, TRENDS ENDOCRIN MET, V11, P163 SAMSON M, 1996, NATURE, V382, P722 SCHLESSINGER J, 2000, CELL, V103, P211 SINGER II, 2001, J VIROL, V75, P3779 TSUJI Y, 2000, J BIOL CHEM, V275, P28144 VENTER JC, 2001, SCIENCE, V291, P1304 VILACORO AJ, 1999, FASEB J, V13, P1699 VILACORO AJ, 2000, P NATL ACAD SCI USA, V97, P3388 WEISS A, 1998, CELL, V94, P277 WHITE JH, 1998, NATURE, V396, P679 XU Y, 1999, P NATL ACAD SCI USA, V96, P151 YOSHIOKA K, 2001, P NATL ACAD SCI USA, V98, P7617 ZENG FY, 1999, J BIOL CHEM, V274, P19487 ZHU XY, 1998, BIOCHEMISTRY-US, V37, P15773 |